CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.
María Ángeles Jiménez-SousaAna Zaida Gómez-MorenoDaniel Pineda-TenorLuz Maria MedranoJuan José Sánchez-RuanoAmanda Fernández-RodríguezTomas Artaza-VarasaJosé Saura-MontalbanSonia Vázquez-MorónPablo RyanSalvador Resino GarcíaPublished in: Clinical and translational medicine (2017)
CXCL9-11 polymorphisms were related to likelihood of having liver fibrosis in HCV-infected patients. Our data suggest that CXCL9-11 polymorphisms may play a significant role against the progression of CHC and could help prioritize antiviral therapy.